Delaet Ingrid sold NBIX
December 31, 2024 · Form 4 insider transaction
Delaet Ingrid sold 272 shares of Neurocrine Biosciences, Inc. at $138.10 per share, a transaction worth $37.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
272
Price
$138.10
Total value
$37.6K
InsiderDelaet Ingrid
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 31, 2024
Filing dateJanuary 3, 2025
Shares owned after2,507
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023.